Skip to main content
PMC home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1996 Sep;34(9):2095–2100. doi: 10.1128/jcm.34.9.2095-2100.1996

Use of multiple PCR primer sets for optimal detection of human papillomavirus.

F Karlsen 1, M Kalantari 1, A Jenkins 1, E Pettersen 1, G Kristensen 1, R Holm 1, B Johansson 1, B Hagmar 1
PMCID: PMC229196  PMID: 8862564

Abstract

Using multiple PCR primer sets, we tried to optimize the detection of human papillomavirus (HPV) in DNA samples isolated from 361 frozen biopsy specimens from patients with invasive cervical carcinomas. The HPVs detected were placed into three distinct groups, including group I/Inex at Telelab (Skien, Norway) and group Ineg and group II at the Norwegian Radium Hospital (Oslo, Norway). The consensus primer sets were Oli-1b-oli-2i, My09-My11, Gp5-Gp6, and Gp(5+)-Gp6+ from the HPV L1 gene and CpI-CpIIG from the E1 gene. Using these consensus primers together with the type-specific primers from E6-E7, we found that 355 patients (98%) were HPV positive. Type-specific primers for HPV types 11, 16, 18, 31, 33, and 35 detected more HPV-infected patients than the most sensitive consensus primer set, while the three consensus primer sets My, Gp/Gp+, and Cp together detected more HPV-positive patients than the type-specific primers. Testing of sensitivity of the PCR with SiHa cells serially diluted in lymphocytes (HPV-negative cells) indicated a detection limit of 6,300 HPV type 16 DNA copies with consensus primers (My, Gp+, and Cp) and 126 original HPV type 16 DNA copies with type-specific primers. Comparison of the amplification results for consensus L1 primers and type-specific E6-E7 primers indicated the presence of L1 deletions in 23 of 56 samples. The conclusion is that in PCR detection systems, multiple consensus primers and type-specific primers should be used in order to detect all patients harboring HPV.

Full Text

The Full Text of this article is available as a PDF (298.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baker C. C., Phelps W. C., Lindgren V., Braun M. J., Gonda M. A., Howley P. M. Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J Virol. 1987 Apr;61(4):962–971. doi: 10.1128/jvi.61.4.962-971.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bosch F. X., Manos M. M., Muñoz N., Sherman M., Jansen A. M., Peto J., Schiffman M. H., Moreno V., Kurman R., Shah K. V. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst. 1995 Jun 7;87(11):796–802. doi: 10.1093/jnci/87.11.796. [DOI] [PubMed] [Google Scholar]
  3. Boshart M., Gissmann L., Ikenberg H., Kleinheinz A., Scheurlen W., zur Hausen H. A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J. 1984 May;3(5):1151–1157. doi: 10.1002/j.1460-2075.1984.tb01944.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chen T. M., Chen C. A., Hsieh C. Y., Chang D. Y., Chen Y. H., Defendi V. The state of p53 in primary human cervical carcinomas and its effects in human papillomavirus-immortalized human cervical cells. Oncogene. 1993 Jun;8(6):1511–1518. [PubMed] [Google Scholar]
  5. Das B. C., Gopalkrishna V., Das D. K., Sharma J. K., Singh V., Luthra U. K. Human papillomavirus DNA sequences in adenocarcinoma of the uterine cervix in Indian women. Cancer. 1993 Jul 1;72(1):147–153. doi: 10.1002/1097-0142(19930701)72:1<147::aid-cncr2820720128>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  6. DeBritton R. C., Hildesheim A., De Lao S. L., Brinton L. A., Sathya P., Reeves W. C. Human papillomaviruses and other influences on survival from cervical cancer in Panama. Obstet Gynecol. 1993 Jan;81(1):19–24. [PubMed] [Google Scholar]
  7. Dürst M., Bosch F. X., Glitz D., Schneider A., zur Hausen H. Inverse relationship between human papillomavirus (HPV) type 16 early gene expression and cell differentiation in nude mouse epithelial cysts and tumors induced by HPV-positive human cell lines. J Virol. 1991 Feb;65(2):796–804. doi: 10.1128/jvi.65.2.796-804.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Eluf-Neto J., Booth M., Muñoz N., Bosch F. X., Meijer C. J., Walboomers J. M. Human papillomavirus and invasive cervical cancer in Brazil. Br J Cancer. 1994 Jan;69(1):114–119. doi: 10.1038/bjc.1994.18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gissmann L., Diehl V., Schultz-Coulon H. J., zur Hausen H. Molecular cloning and characterization of human papilloma virus DNA derived from a laryngeal papilloma. J Virol. 1982 Oct;44(1):393–400. doi: 10.1128/jvi.44.1.393-400.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Guerrero E., Daniel R. W., Bosch F. X., Castellsagué X., Muñoz N., Gili M., Viladiu P., Navarro C., Zubiri M. L., Ascunce N. Comparison of ViraPap, Southern hybridization, and polymerase chain reaction methods for human papillomavirus identification in an epidemiological investigation of cervical cancer. J Clin Microbiol. 1992 Nov;30(11):2951–2959. doi: 10.1128/jcm.30.11.2951-2959.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hagmar B., Johansson B., Kalantari M., Petersson Z., Skyldberg B., Walaas L. The incidence of HPV in a Swedish series of invasive cervical carcinoma. Med Oncol Tumor Pharmacother. 1992;9(3):113–117. doi: 10.1007/BF02987743. [DOI] [PubMed] [Google Scholar]
  12. Herrington C. S., Anderson S. M., Bauer H. M., Troncone B., de Angelis M. L., Noell H., Chimera J. A., Van Eyck S. L., McGee J. O. Comparative analysis of human papillomavirus detection by PCR and non-isotopic in situ hybridisation. J Clin Pathol. 1995 May;48(5):415–419. doi: 10.1136/jcp.48.5.415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hudson J. B., Bedell M. A., McCance D. J., Laiminis L. A. Immortalization and altered differentiation of human keratinocytes in vitro by the E6 and E7 open reading frames of human papillomavirus type 18. J Virol. 1990 Feb;64(2):519–526. doi: 10.1128/jvi.64.2.519-526.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ikenberg H., Sauerbrei W., Schottmüller U., Spitz C., Pfleiderer A. Human papillomavirus DNA in cervical carcinoma--correlation with clinical data and influence on prognosis. Int J Cancer. 1994 Nov 1;59(3):322–326. doi: 10.1002/ijc.2910590306. [DOI] [PubMed] [Google Scholar]
  15. Jenkins A., Kristiansen B. E., Ask E., Oskarsen B., Kristiansen E., Lindqvist B., Trope C., Kjørstad K. Detection of genital papillomavirus types by polymerase chain reaction using common primers. APMIS. 1991 Jul;99(7):667–673. doi: 10.1111/j.1699-0463.1991.tb01244.x. [DOI] [PubMed] [Google Scholar]
  16. Jeon S., Allen-Hoffmann B. L., Lambert P. F. Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J Virol. 1995 May;69(5):2989–2997. doi: 10.1128/jvi.69.5.2989-2997.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Karlsen F., Kristensen G., Holm R., Chitemerere M., Berner A., Hagmar B. M. High incidence of human papillomavirus in 146 cervical carcinomas. A study using three different pairs of consensus primers, and detecting viral genomes with putative deletions. Eur J Cancer. 1995;31A(9):1511–1516. doi: 10.1016/0959-8049(95)00206-x. [DOI] [PubMed] [Google Scholar]
  18. Karlsen F., Rabbitts P. H., Sundresan V., Hagmar B. PCR-RFLP studies on chromosome 3p in formaldehyde-fixed, paraffin-embedded cervical cancer tissues. Int J Cancer. 1994 Sep 15;58(6):787–792. doi: 10.1002/ijc.2910580606. [DOI] [PubMed] [Google Scholar]
  19. Karlsen F., Steen H. B., Nesland J. M. SYBR green I DNA staining increases the detection sensitivity of viruses by polymerase chain reaction. J Virol Methods. 1995 Sep;55(1):153–156. doi: 10.1016/0166-0934(95)00053-w. [DOI] [PubMed] [Google Scholar]
  20. Kristiansen E., Jenkins A., Kristensen G., Ask E., Kaern J., Abeler V., Lindqvist B. H., Tropé C., Kristiansen B. E. Human papillomavirus infection in Norwegian women with cervical cancer. APMIS. 1994 Feb;102(2):122–128. doi: 10.1111/j.1699-0463.1994.tb04856.x. [DOI] [PubMed] [Google Scholar]
  21. Matsukura T., Kanda T., Furuno A., Yoshikawa H., Kawana T., Yoshiike K. Cloning of monomeric human papillomavirus type 16 DNA integrated within cell DNA from a cervical carcinoma. J Virol. 1986 Jun;58(3):979–982. doi: 10.1128/jvi.58.3.979-982.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Meijer C. J., van den Brule A. J., Snijders P. J., Helmerhorst T., Kenemans P., Walboomers J. M. Detection of human papillomavirus in cervical scrapes by the polymerase chain reaction in relation to cytology: possible implications for cervical cancer screening. IARC Sci Publ. 1992;(119):271–281. [PubMed] [Google Scholar]
  23. Monk B. J., Cook N., Ahn C., Vasilev S. A., Berman M. L., Wilczynski S. P. Comparison of the polymerase chain reaction and Southern blot analysis in detecting and typing human papilloma virus deoxyribonucleic acid in tumors of the lower female genital tract. Diagn Mol Pathol. 1994 Dec;3(4):283–291. doi: 10.1097/00019606-199412000-00012. [DOI] [PubMed] [Google Scholar]
  24. Muñoz N., Bosch F. X., de Sanjosé S., Shah K. V. The role of HPV in the etiology of cervical cancer. Mutat Res. 1994 Mar 1;305(2):293–301. doi: 10.1016/0027-5107(94)90249-6. [DOI] [PubMed] [Google Scholar]
  25. Muñoz N., Bosch F. X., de Sanjosé S., Tafur L., Izarzugaza I., Gili M., Viladiu P., Navarro C., Martos C., Ascunce N. The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int J Cancer. 1992 Nov 11;52(5):743–749. doi: 10.1002/ijc.2910520513. [DOI] [PubMed] [Google Scholar]
  26. Münger K., Phelps W. C., Bubb V., Howley P. M., Schlegel R. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol. 1989 Oct;63(10):4417–4421. doi: 10.1128/jvi.63.10.4417-4421.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Prussia P. R., ter Schegget J., Smits H. L. Detection of oncogenic HPV DNA by a consensus polymerase chain reaction method in genital carcinomas in twenty women in Barbados. West Indian Med J. 1993 Dec;42(4):144–146. [PubMed] [Google Scholar]
  28. Romanczuk H., Howley P. M. Disruption of either the E1 or the E2 regulatory gene of human papillomavirus type 16 increases viral immortalization capacity. Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):3159–3163. doi: 10.1073/pnas.89.7.3159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Schwarz E., Freese U. K., Gissmann L., Mayer W., Roggenbuck B., Stremlau A., zur Hausen H. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature. 1985 Mar 7;314(6006):111–114. doi: 10.1038/314111a0. [DOI] [PubMed] [Google Scholar]
  30. Snijders P. J., van den Brule A. J., Schrijnemakers H. F., Snow G., Meijer C. J., Walboomers J. M. The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomavirus genotypes. J Gen Virol. 1990 Jan;71(Pt 1):173–181. doi: 10.1099/0022-1317-71-1-173. [DOI] [PubMed] [Google Scholar]
  31. Tieben L. M., ter Schegget J., Minnaar R. P., Bouwes Bavinck J. N., Berkhout R. J., Vermeer B. J., Jebbink M. F., Smits H. L. Detection of cutaneous and genital HPV types in clinical samples by PCR using consensus primers. J Virol Methods. 1993 May;42(2-3):265–279. doi: 10.1016/0166-0934(93)90038-s. [DOI] [PubMed] [Google Scholar]
  32. Wagatsuma M., Hashimoto K., Matsukura T. Analysis of integrated human papillomavirus type 16 DNA in cervical cancers: amplification of viral sequences together with cellular flanking sequences. J Virol. 1990 Feb;64(2):813–821. doi: 10.1128/jvi.64.2.813-821.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Williamson A. L., Brink N. S., Dehaeck C. M., Ovens S., Soeters R., Rybicki E. P. Typing of human papillomaviruses in cervical carcinoma biopsies from Cape Town. J Med Virol. 1994 Jul;43(3):231–237. doi: 10.1002/jmv.1890430307. [DOI] [PubMed] [Google Scholar]
  34. de Roda Husman A. M., Walboomers J. M., van den Brule A. J., Meijer C. J., Snijders P. J. The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol. 1995 Apr;76(Pt 4):1057–1062. doi: 10.1099/0022-1317-76-4-1057. [DOI] [PubMed] [Google Scholar]
  35. ter Meulen J., Eberhardt H. C., Luande J., Mgaya H. N., Chang-Claude J., Mtiro H., Mhina M., Kashaija P., Ockert S., Yu X. Human papillomavirus (HPV) infection, HIV infection and cervical cancer in Tanzania, east Africa. Int J Cancer. 1992 Jun 19;51(4):515–521. doi: 10.1002/ijc.2910510403. [DOI] [PubMed] [Google Scholar]
  36. van den Brule A. J., Snijders P. J., Gordijn R. L., Bleker O. P., Meijer C. J., Walboomers J. M. General primer-mediated polymerase chain reaction permits the detection of sequenced and still unsequenced human papillomavirus genotypes in cervical scrapes and carcinomas. Int J Cancer. 1990 Apr 15;45(4):644–649. doi: 10.1002/ijc.2910450412. [DOI] [PubMed] [Google Scholar]
  37. zur Hausen H., de Villiers E. M. Human papillomaviruses. Annu Rev Microbiol. 1994;48:427–447. doi: 10.1146/annurev.mi.48.100194.002235. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES